Professor Malcolm Mason was a world-leading doctor who specialised in running clinical trials from Cardiff. This has improved treatment for men with prostate cancer.
Research in Cardiff is supporting the STAMPEDE trial, one of the largest trials of its kind, which found that adding abiraterone to hormone therapy at the start of treatment can greatly improve survival.
This is only one of the projects you could contribute to by leaving a gift in your Will to Cancer Research UK.
Gifts in Wills breathe life into researchers’ work by funding over a third of their life-saving research. Legacies enable long-term research projects that allow scientists to achieve breakthroughs every day. Each breakthrough inspires the next, leading us to a world where everybody can lead longer, better lives, free from the fear of cancer.
As the world’s leading Cancer Research charity, Cancer Research UK are at the forefront of the global fight against cancer, bringing together millions of people who share their determination to beat it.
In the past 40 years, cancer survival has doubled in part thanks to Cancer Research UK’s pioneering research, funded by the generosity of their supporters. Cancer Research UK wants to accelerate progress and see 3 in 4 people surviving their cancer by 2034. None of this will be possible without the help of their supporters.
1 in 2 people will get cancer in their lifetime*. All of us can support the research that will beat it.
Pledge to leave a gift in your Will to Cancer Research UK today by visiting
*Ahmad AS et al, British Journal of Cancer, 2015
